Although most parents require that their children receive only medication approved by the FDA, few parents want their kids to participate in new drug research.
Although most parents require that their children receive only medication approved by the FDA, few parents want their kids to participate in new drug research.
According to results from the University of Michigan's C.S. Mott Children's Hospital National Poll on Children's Health, 77% of parents want only FDA-approved treatments for their kids, while 30% would allow their children to participate in clinical studies that involve new treatments.
However, if the risk of harm is minimal, many parents would consider allowing their children to participate: 36% would consider child participation if their child had the same disease as the one being studied, and 25% would allow their child to be a healthy volunteer.
The poll also found that 92% of parents have never been asked to have their children participate in clinical research.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.